Ability of Escherichia coli O157:H7 isolates to colonize the intestinal tract of conventional adult CD1 mice is transient

Canadian Journal of Microbiology

Volumn 47, Issue 1, 2001, Pages 91-95

  Conlan, J W ^a   Bardy, S L ^a   KuoLee, R ^a   Webb, A ^a   Perry, M B ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; VEROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIUM COLONY; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI O157; FEMALE; INTESTINE; INTESTINE INFECTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINES; MICE; SHIGA-LIKE TOXIN II; TIME FACTORS; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0035136336     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjm-47-1-91     Document Type: Article

References (26)

1. Clinical trials of synsorb-Pk in preventing hemolytic uremic syndrome
2. A new strain of Yersinia enterocolitica pathogenic for rodents
3. Experimental Yersinia enterocolitica infection in mice: Kinetics of growth
4. Immunity to enteric infection in mice
5. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7
6. Parenteral immunization with a glyco-conjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen
7. Salmonella landau as a live vaccine against Escherichia coli O157:H7 investigated in a mouse model of intestinal colonization
8. Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogen
9. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice
10. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing
11. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H7 in mitomycin-treated mice
12. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents
13. Ecology of Escherichia coli O157:H7 in cattle and management practices
14. The role of lipopolysaccharide and shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection
15. Cell-mediated immunity to intestinal infection
16. Development of a mouse model of Helicobacter pylori infection that mimics human disease
17. Treatment of disease due to Shiga toxin-producing Escherichia coli: Infectious disease management
18. Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157:H7
19. Identification of Escherichia coli serotype O157 strains by using a monoclonal antibody
20. Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin
21. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933
22. Detection of serum and faecal antibodies in haemorrhagic colitis caused by Escherichia coli O157
23. Escherichia coli O157:H7 infection in humans
24. Public health perspective on immunoprophylactic strategies for Escherichia coli O157:H7: Who or what would we immunize?
25. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7
26. Acute renal tubular necrosis and death of mice orally infected with Esherichia coli strains that produce Shiga-like toxin type II